Are there gender differences in autism prevalence?

Yes, autism is more prevalent in males, with a ratio of about 4:1 compared to females. While diagnostic biases and masking behaviors in girls might play a role, biological differences in brain maturation and resilience, possibly linked to the SRY gene, are also considered contributing factors.

What is the role of genetics in autism, and what are channelopathies and chromatinopathies?

Genetics play a strong role in autism, with hundreds of associated genes. These genes can encode proteins for synapses (synaptopathies), ion channels (channelopathies), or DNA packing (chromatinopathies). These genetic variations can disrupt nervous system development and contribute to autism's complex biology.

What are the common challenges in understanding and treating brain disorders like autism?

Key challenges stem from the human brain's inaccessibility and the lack of precise biological markers for disorders like autism, which are often defined behaviorally. This disconnect makes molecular understanding and targeted therapeutic development difficult, leading to slower progress compared to diseases with clear biological definitions.

How does CRISPR gene therapy work, and what are its current limitations for brain disorders?

CRISPR precisely edits DNA, allowing for genetic defect correction. While promising, its application in brain disorders faces challenges: effective delivery to all affected cells, the size of genes that can be carried by viral vectors, and the irreversible nature of genetic modifications, necessitating high precision and safety.

What was the significance of Shinya Yamanaka's discovery of induced pluripotent stem cells (iPSCs)?

Yamanaka's breakthrough allowed adult skin cells to be reprogrammed into iPSCs using specific genetic factors. This eliminated the need for embryonic stem cells, sidestepping ethical debates and providing an unlimited, patient-specific source of pluripotent cells for modeling diseases and developing therapies.

What are the risks associated with unproven stem cell injections, particularly for autism?

Unproven stem cell injections, often sought abroad by desperate parents, carry significant risks. These include unknown cell origins, lack of biological rationale for conditions like autism, and potential adverse effects such as infection, paralysis, or even permanent vision loss, as these procedures are unregulated and lack scientific validation.

How do brain organoids and assemblids contribute to understanding human brain development?

Brain organoids are 3D cultures that recapitulate human brain development, including an intrinsic developmental clock. Assemblids combine different organoids to create complex neural circuits, allowing researchers to study long-distance neuronal interactions and emergent properties relevant to psychiatric and neurological disorders.

How are assemblids being used to model specific diseases like Timothy Syndrome and epilepsy?

Assemblids have been instrumental in modeling Timothy Syndrome, revealing specific defects in calcium channels and leading to a nucleic acid-based therapeutic. They are also used to study intractable epilepsies by mimicking complex neural networks, allowing analysis of genetic mutations and their effects on circuit activity.

What are the current ethical considerations in using organoids and assemblids, especially when transplanted into animals?

Ethical concerns include ensuring informed consent for human cell use, minimizing harm to recipient animals, and addressing potential issues of consciousness or pain in complex neural constructs. Responsible communication, avoiding terms like 'mini-brains,' is crucial to maintain public trust and prevent misinterpretation of research capabilities.

What is the biological timer in brain development, and what does it imply?

The biological timer is an intrinsic mechanism in human neurons that allows them to keep track of developmental time, even in a dish. This is exemplified by molecular switches occurring at specific developmental time points, like the transition of NMDA receptor subunits at nine months in organoids, mirroring in vivo changes. Understanding this 'timer' holds potential for manipulating cell aging and rejuvenation.

How does gender influence outcomes in premature birth, and what does this suggest about brain resilience?

Female premature babies generally exhibit better outcomes than males. This indicates inherent biological differences in brain resilience and maturation rates between sexes, with female nervous systems potentially being more robust or maturing differently, allowing them to better withstand early life challenges.

How do societal factors influence funding for brain disease research, particularly for autism versus schizophrenia?

Societal perceptions and advocacy significantly impact research funding. Autism, often affecting children, garners considerable public sympathy and lobbying, directing more funds. In contrast, schizophrenia, frequently manifesting in adulthood and associated with stigma, has historically received less research investment despite its significant impact.

How far along is the development of a therapeutic for Timothy Syndrome, and what is its significance?

A therapeutic for Timothy Syndrome, a rare genetic form of autism, is in preparation for clinical trials. This therapeutic, developed exclusively with human stem cell models, involves a small nucleic acid that corrects a calcium channel defect. Its significance lies in being a potential first-in-class treatment for a psychiatric disease developed without animal models, offering hope for highly specific genetic therapies.

Curing Autism, Epilepsy & Schizophrenia with Stem Cells | Dr. Sergiu Pașca

Andrew Huberman

Science & Technology3 min read144 min video

Aug 18, 2025|83,319 views|2,201|395

andrew huberman huberman lab podcast huberman podcast dr. andrew huberman neuroscience huberman lab andrew huberman podcast the huberman lab podcast science podcast

Save to Pod

Key Moments

TL;DR

Stem cells, organoids, and assembloids are revolutionizing brain disorder research and treatment.

Key Insights

Autism is a complex spectrum with a strong genetic component, and the increasing prevalence is still not fully understood.

Induced pluripotent stem cells (iPSCs) offer a way to study neurological and psychiatric disorders without ethical concerns associated with embryonic stem cells.

Organoids and assembloids, 3D human brain cell cultures, allow for the study of brain development and disease mechanisms in ways previously impossible.

Gene therapy and CRISPR technology hold promise for treating genetic brain disorders, though challenges remain in delivery and precision.

Assembloids are crucial for studying how distant brain regions and circuits interact, revealing disease phenotypes not visible in simpler models.

Ethical considerations, particularly regarding potential sentience and precise nomenclature, are paramount as these technologies advance.

UNDERSTANDING THE SPECTRUM OF AUTISM

Autism is a behaviorally defined neurodevelopmental disorder, presenting as a broad spectrum. Recent data indicates its prevalence is nearly 3% of the general population, a significant increase from previous decades. While some individuals with autistic traits lead functional lives, others experience profound impairments requiring lifelong care. The exact reasons for the rising prevalence are multifaceted, involving potential changes in diagnostic criteria, increased detection, and a greater understanding of its strong heritable component. The condition is not a single disease, akin to how 'fever' was once a broad diagnosis before underlying biological causes were identified.

STEM CELLS: FROM EMBRYONIC TO INDUCED PLURIPOTENT

The field of stem cell research has been transformed by the discovery of induced pluripotent stem cells (iPSCs). While embryonic stem cells offered great potential, their use raised significant ethical debates. However, Dr. Shinya Yamanaka's groundbreaking work in reprogramming adult cells, like skin cells, back into a pluripotent state using specific factors, bypassed these ethical concerns. These iPSCs, now readily available and expandable, can differentiate into virtually any cell type, providing an essential tool for studying human development and disease without invasive procedures.

ORGANOIDS: MODELING HUMAN BRAIN DEVELOPMENT IN A DISH

Organoids are three-dimensional self-organizing cultures derived from iPSCs that mimic early stages of human brain development. By culturing iPSCs in specific media, scientists can coax them to form neural structures that recapitulate key developmental timelines and cellular diversity. These 'mini-brains' allow researchers to observe fundamental aspects of neural development, such as the timing of cell differentiation and the maturation of neuronal properties like ion channel function, even revealing intrinsic biological clocks that dictate developmental progression.

ASSEMBLOIDS: RECREATING FUNCTIONAL BRAIN CIRCUITS

Moving beyond simple organoids, assembloids integrate different types of brain organoids or neural cell populations to recreate more complex, functional circuits. This allows for the study of cell migration, connectivity, and the emergent properties of neural networks. For instance, assembloids can model the migration of inhibitory neurons from deep brain structures to the cortex or even create rudimentary cortical-spinal-muscle pathways capable of generating coordinated movements. This capability is critical for understanding disorders where connectivity, rather than cell type, is the primary deficit.

THERAPEUTIC POTENTIAL AND GENETIC APPROACHES

The insights gained from organoids and assembloids are paving the way for novel therapeutic strategies. Gene therapy and CRISPR technology offer the potential to correct genetic defects underlying brain disorders. For conditions like Timothy syndrome, a severe genetic disorder, research has led to a potential therapy involving a small piece of nucleic acid that restores normal ion channel function. This development, exclusively based on human stem cell model studies, is progressing towards clinical trials, highlighting the power of these models in translating basic science discoveries into treatments.

ETHICAL CONSIDERATIONS AND FUTURE DIRECTIONS

The development of increasingly complex brain models raises significant ethical questions. These range from consent for cell usage and animal welfare in transplantation studies to the potential for emergent properties like sentience in advanced assembloids. The precise nomenclature for these models is crucial to avoid misinterpretation and to communicate research accurately to the public. While the potential for enhancement or 'superhuman' capabilities is a concern, the primary focus remains on understanding and treating devastating neurological and psychiatric diseases, guided by rigorous ethical oversight and collaborative scientific efforts.

Mentioned in This Episode

●Supplements

●Products

●Software & Apps

●Companies

●Organizations

●Concepts

●People Referenced

Common Questions

Autism is a complex spectrum condition, behaviorally defined, with no specific biomarker, showing a prevalence of almost 3% in the general population. It encompasses a wide range of presentations, from functional autistic traits to profound autism requiring lifelong care, indicating it is not a single disease.

Topics

Human Brain Development Organoids Assemblids Neuroscience Ethics Genetic Disorders Neurological Diseases Psychiatric Disorders Dystonia

Mentioned in this video

conceptSRY gene

A gene on the Y chromosome (or capable of conferring maleness) that may be linked to the higher prevalence of autism in males.

conceptTimothy Syndrome

A genetic form of autism caused by a single letter mutation in a calcium channel gene, leading to severe presentation including intellectual disability and epilepsy. Dr. Pasca's lab developed a therapeutic for this condition.

personLubbert Stryer

A renowned biochemist (author of the 'big red biochemistry book') and amazing communicator, who developed the gene chip, and greatly admired Dr. Pasca's work on demystifying psychiatric disease.

personYoshiki Sasai

Japanese scientist who pioneered 3D cultures for developmental studies, making an optic cup.

personRudolf Llinás

A neuroscientist possibly credited with the theory that the nervous system evolved for movement.

companyOrchid

A company that offers deep sequencing of embryos in IVF, raising ethical questions about eugenics.

personEJ Chichilnisky

A scientist at Stanford working on developing technologies to cure blindness, potentially involving engineered eyes.

personSergiu Pasca

Professor of Psychiatry and Behavioral Sciences and Director of the Stanford Brain Organogenesis Program, pioneering research on organoids and assemblids.

conceptOrganoids

Three-dimensional human brain cultures made from induced pluripotent stem cells, grown in a dish, capable of recapitulating aspects of brain development and used to study neurological disorders.

personBen Barres

Former colleague of Andrew Huberman and Sergiu Pasca at Stanford, a world-renowned neuroscientist known for his work on glial cells, who encouraged Pasca to find a new name for assemblids.

personBob Desimone

Former head of the National Institutes of Mental Health, who discussed the disparity in funding between autism and schizophrenia research.

productHelix Sleep mattresses and pillows

Customized mattresses and pillows tailored to individual sleep needs, improving sleep quality.

drugThalidomide

A drug previously prescribed to pregnant mothers to prevent miscarriage, known to increase the risk for autism and cause major birth defects.

personMichael Snyder

Chair of Genetics at Stanford, who believes that immortalization of human tissues will be possible within Andrew Huberman's lifetime.

personDan Palanker

A scientist at Stanford also working on developing technologies to cure blindness.

conceptAssemblids

Complex neural circuits formed by combining different brain region organoids, allowing the study of long-distance neuronal connections and interactions, particularly useful for understanding psychiatric disorders.

personDavid Ginty

Harvard scientist who conducted experiments on autism by inducing mutations in the periphery of mouse models.

personNero Shaw

Colleague of Andrew Huberman who discussed the SRY gene and sex differences in a previous podcast episode.

concept22q11.2 deletion syndrome

The most common microdeletion in humans (1 in 3,000 births), associated with cardiac and immune issues, and a 30% risk for schizophrenia and autism. Its penetrance is variable.

supplementFollistatin gene therapy